As speculation mounts over the next Federal Reserve leadership, top economists point to Kevin Warsh's crisis-era experience as a strength, but warn his legacy will hinge on a single, monumental challenge: shielding interest-rate policy from political influence.
Goldman Sachs Group (GS) has approved a significant dividend increase and projects a robust earnings outlook for Corporate America, fueling debate over whether its strong share price momentum has outpaced its fundamental valuation.
Eastern Bankshares (EBC) has delivered impressive multi-year returns for shareholders, but a closer look reveals a complex valuation picture. While one model suggests deep undervaluation, traditional metrics paint a different story, leaving investors to weigh competing signals.
Revvity (NYSE: RVTY) surged past fourth-quarter expectations and issued an upbeat 2026 outlook, driven by robust demand in its diagnostics division. The medical equipment maker's performance highlights a sector-wide resilience despite ongoing softness in academic research funding.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
Amid a mixed market landscape, corporate insiders are placing significant bets on select small-cap stocks. We analyze three companies where recent insider buying and strategic moves signal potential value, despite broader economic headwinds.
Oracle shares slid in premarket trading after the company unveiled plans to raise up to $50 billion this year to fuel its cloud and AI expansion, prompting investor unease over its growing debt burden and the long-term payoff of the sector's spending spree.
Under Armour faces a pivotal moment as a significant insider purchase coincides with a high-stakes legal loss and the exit of its Chief Product Officer, testing investor confidence in the embattled sportswear brand's turnaround strategy.
A deep dive into Truist Financial's valuation suggests its current share price may not fully reflect its underlying earnings power and book value, presenting a potential opportunity for investors.
A woman identifying herself as Justin Sun's former partner has leveled serious market manipulation claims against the Tron founder, alleging he used employee-linked Binance accounts to inflate TRX's price during the 2017-2018 crypto boom before cashing out, leaving retail investors holding the bag.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
While recent market surges have lifted several names, discerning investors must separate fleeting hype from durable growth. We analyze two companies capitalizing on structural shifts and one whose valuation appears dangerously disconnected from fundamentals.
Nominee Kevin Warsh's desire to aggressively shrink the Federal Reserve's multi-trillion dollar holdings collides with a financial system now structurally dependent on ample liquidity, making rapid contraction a high-risk endeavor, analysts say.
While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, their low price tags can sometimes mask underlying vulnerabilities. We examine three such companies where caution may be prudent.
Amid a contentious federal immigration operation, Minneapolis residents report heightened tensions and an increased security presence, contradicting official promises of de-escalation. The arrests of journalists and unresolved fatal shootings have intensified scrutiny and community-led resistance.
While recent performance has moderated, Mercantile Bank Corporation (NASDAQ:MBWM) has rewarded long-term investors with a total shareholder return more than double the broader market's gains over the past half-decade, driven by consistent earnings growth and dividends.
The private equity giant announced a dividend increase to $1.49 per share, pushing its yield above the industry average. While future earnings projections are robust, analysts flag concerns over the current payout ratio and the firm's mixed dividend history.
While analyst price targets often paint a rosy picture, a closer look reveals a more nuanced reality. We examine one favored stock with solid fundamentals and two others where the Street's optimism may be overlooking critical risks.
In a rare break from Wall Street's typically optimistic consensus, a handful of prominent stocks are receiving bearish price targets that signal deep-seated concerns. We examine the challenges facing Deckers, MSC Industrial, and Guardant Health, and why investors might want to look elsewhere.
